Not received any observation from USFDA audit: Claris Lifesciences Ruby Khatun Khatun3 Jun 2017 9:26 AM ISTNew Delhi: Claris Lifesciences underwent an audit by the USFDA for pharmacovigilance in the last week of May and has not received any...
EU approves Biogen's Spinraza for lead genetic cause of infant death Ruby Khatun Khatun3 Jun 2017 9:22 AM ISTBiogen Inc on Thursday said its drug, Spinraza, had secured European Union approval to treat spinal muscular atrophy (SMA), a leading genetic cause of...
Narayana Hrudayalaya Q4FY17 standalone net profit rises 31% Ruby Khatun Khatun2 Jun 2017 6:27 PM ISTBengaluru: Narayana Hrudayalaya Limited, a leading healthcare service provider in India, announced its financial results for the fourth quarter (Q4...
Eris Lifesciences plans to raise Rs 2,000 crore through IPO Ruby Khatun Khatun2 Jun 2017 6:24 PM ISTMumbai: Eris Lifesciences, ahmedabad-based pharmaceuticals company which makes and sells branded generics in select therapeutic areas with the focus...
AstraZeneca Pharma receives nod from DCGI for Osimertinib tablets Ruby Khatun Khatun2 Jun 2017 11:15 AM ISTIndia: AstraZeneca Pharma Limited announced that it has received import and market permission in Form 45 (Marketing Authorisation) from the Drug...
Aurobindo Pharma receives USFDA approval to manufacture ADHD drug Ruby Khatun Khatun2 Jun 2017 10:25 AM ISTNew Delhi: Aurobindo Pharma has received final approval from the US health regulator for generic version of Strattera capsules, used in treatment of...
Sun Pharma Warns ‘New Normal’ Will Push Down Its Sales Next Year Ruby Khatun Khatun2 Jun 2017 9:54 AM IST(Bloomberg) -- Sun Pharmaceutical Industries Ltd., India’s largest drugmaker, warned investors that sales could decline in the coming year amid...
Rohto Pharma invests Rs 32 crore in SastaSundar Healthbuddy Ruby Khatun Khatun2 Jun 2017 9:54 AM ISTNew Delhi: Japanese firm Rohto Pharmaceutical Co has invested USD 5 million (over Rs 32 crore) to acquire 13 per cent stake in SastaSundar Healthbuddy...
Cadila Healthcare posts Q4 net profit at Rs 385.5 cr Ruby Khatun Khatun2 Jun 2017 9:50 AM ISTNew Delhi: Drug firm Cadila Healthcare reported consolidated net profit at Rs 385.5 crore for the quarter ended March 31.The company had posted a net...
Glenmark gets USFDA nod for ADHD drug Ruby Khatun Khatun2 Jun 2017 9:21 AM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for generic version of Strattera capsules, used in the...
Teva Pharmaceutical migraine drug clears late-stage study Ruby Khatun Khatun2 Jun 2017 9:21 AM ISTTeva Pharmaceutical Industries Ltd said on Wednesday its experimental drug to prevent migraine cleared a late-stage study, paving the way for a U.S....
Fortis Healthcare reports a Q4 net loss at Rs 37.52 crore, Check out details Ruby Khatun Khatun1 Jun 2017 12:49 PM ISTFortis Healthcare reported a consolidated net loss of Rs 37.52 crore for the fourth quarter ended March 31, 2017.The company had posted a net loss of...
